{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:56:45Z","timestamp":1793447805493,"version":"4.5.0"},"reference-count":43,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2020,1,2]]},"DOI":"10.1080\/09546634.2017.1363850","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T04:57:51Z","timestamp":1502254671000},"page":"2-12","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Utility of boron in dermatology"],"prefix":"10.1080","volume":"31","author":[{"given":"David G.","family":"Jackson","sequence":"first","affiliation":[{"name":"Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine","place":["Winston-Salem, North Carolina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah A.","family":"Cardwell","sequence":"additional","affiliation":[{"name":"Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine","place":["Winston-Salem, North Carolina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6219-9460","authenticated-orcid":false,"given":"Elias","family":"Oussedik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-6289","authenticated-orcid":false,"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine","place":["Winston-Salem, North Carolina"]},{"name":"Department of Pathology, Wake Forest School of Medicine","place":["Winston-Salem, North Carolina"]},{"name":"Department of Public Health Sciences, Wake Forest School of Medicine","place":["Winston-Salem, North Carolina"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,10,17]]},"reference":[{"key":"e_1_3_2_2_1","first-page":"35","article-title":"Nothing Boring About Boron","volume":"14","author":"Pizzorno L","year":"2015","unstructured":"Pizzorno L. Nothing Boring About Boron. Integr Med (Encinitas). 2015;14:35\u201348.","journal-title":"Integr Med (Encinitas)"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/embor.2009.2"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1039\/c0cs00131g"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.10043"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.09.71"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002635"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516282"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-665018"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.4994"},{"key":"e_1_3_2_11_1","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/MOT.0000000000000252","article-title":"Bortezomib in kidney transplantation","volume":"20","author":"Shah N","year":"2015","unstructured":"Shah N, Meouchy J, Qazi Y. Bortezomib in kidney transplantation. Curr Opin Organ Transplant. 2015;20:652\u2013656.","journal-title":"Curr Opin Organ Transplant"},{"key":"e_1_3_2_12_1","doi-asserted-by":"crossref","DOI":"10.5070\/D3205022608","article-title":"A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology","volume":"20","author":"Moustafa F","year":"2014","unstructured":"Moustafa F, Feldman SR. A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology. Dermatol Online J. 2014;20(5):22608.","journal-title":"Dermatol Online J"},{"key":"e_1_3_2_13_1","first-page":"13","article-title":"From the test tube to the treatment room: fundamentals of boron-containing compounds and their relevance to dermatology","volume":"7","author":"Del Rosso JQ","year":"2014","unstructured":"Del Rosso JQ, Plattner JJ. From the test tube to the treatment room: fundamentals of boron-containing compounds and their relevance to dermatology. J Clin Aesthet Dermatol. 2014;7:13\u201321.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_2_14_1","unstructured":"Wigger-Alberti WZ. Dermal tolerability and preliminary efficacy of AN2728 and A2898 novel boron-based small molecules in the treatment of psoriasis. Poster presented at: Annual Meeting of the European Society for Dermatologic Research; 2011 Sep 7\u201310; Barcelona Spain."},{"key":"e_1_3_2_15_1","doi-asserted-by":"crossref","unstructured":"Akama T Baker SJ Zhang YK et\u00a0al. Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis. Bioorg Med Chem Lett. 2009;19(8):2129\u20132132.","DOI":"10.1016\/j.bmcl.2009.03.007"},{"key":"e_1_3_2_16_1","first-page":"364","article-title":"Therapeutic benefit of PDE4 inhibitors in inflammatory diseases","volume":"8","author":"Dastidar SG","year":"2007","unstructured":"Dastidar SG, Rajagopal D, Ray A. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases. Curr Opin Investig Drugs. 2007;8:364\u2013372.","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_3_2_17_1","first-page":"390","article-title":"Crisaborole topical ointment, 2%\u202f: a nonsteroidal, topical, anti - inflammatory phosphodiesterase 4 inhibitor in clinical development for the treatment of atopic dermatitis","volume":"15","author":"Jarnagin K","year":"2016","unstructured":"Jarnagin K, Chanda S, Coronado BD, et\u00a0al. Crisaborole topical ointment, 2%\u202f: a nonsteroidal, topical, anti - inflammatory phosphodiesterase 4 inhibitor in clinical development for the treatment of atopic dermatitis. J Drugs Dermatol. 2016;15:390\u2013396.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2012.07.058"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","unstructured":"SJ Baker * Y-K Zhang T Akama et\u00a0al. Discovery of a new boron-containing antifungal agent 5-fluoro-1 3-dihydro-1-hydroxy-2 1- benzoxaborole (AN2690) for the potential treatment of onychomycosis. J Med Chem. 2006;49(15):4447\u20134450.","DOI":"10.1021\/jm0603724"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S81944"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1142189"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12872"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0204-6"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.05.046"},{"key":"e_1_3_2_25_1","first-page":"1108","article-title":"Crisaborole topical ointment, 2% in adults with atopic dermatitis: a phase 2a, vehicle-controlled, proof-of-concept study","volume":"14","author":"Murrell DF","year":"2015","unstructured":"Murrell DF, Gebauer K, Spelman L, et\u00a0al. Crisaborole topical ointment, 2% in adults with atopic dermatitis: a phase 2a, vehicle-controlled, proof-of-concept study. J Drugs Dermatol. 2015;14:1108\u20131112.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_26_1","first-page":"1394","article-title":"A Phase 2, randomized, controlled, dose-ranging study evaluating crisaborole topical ointment, 0.5% and 2% in adolescents with mild to moderate atopic dermatitis","volume":"14","author":"Stein Gold LF","year":"2015","unstructured":"Stein Gold LF, Spelman L, Spellman MC, et\u00a0al. A Phase 2, randomized, controlled, dose-ranging study evaluating crisaborole topical ointment, 0.5% and 2% in adolescents with mild to moderate atopic dermatitis. J Drugs Dermatol. 2015;14:1394\u20131399.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_27_1","unstructured":"Beutner KR Sanders VH. An open-label multi-dose study of the absorption and systemic pharmacokinetics of AN2690 applied as a 7.5% solution to all toenails of adult patients with moderate to severe onychomycosis. 2007."},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20901"},{"key":"e_1_3_2_29_1","first-page":"1124","article-title":"The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis","volume":"13","author":"Toledo-Bahena ME","year":"2014","unstructured":"Toledo-Bahena ME, Bucko A, Ocampo-Candiani J, et\u00a0al. The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis. J Drugs Dermatol. 2014;13:1124\u20131132.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.04.010"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000443773"},{"key":"e_1_3_2_32_1","first-page":"89","article-title":"Evaluation of the appearance of nail polish following daily treatment of ex vivo human fingernails with topical solutions of tavaborole or efinaconazole","volume":"15","author":"Vlahovic T","year":"2016","unstructured":"Vlahovic T, Coronado D, Chanda S, et\u00a0al. Evaluation of the appearance of nail polish following daily treatment of ex vivo human fingernails with topical solutions of tavaborole or efinaconazole. J Drugs Dermatol. 2016;15:89\u201394.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0603724"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.21779"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.5b00291"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/1091581814545245"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.116.232819"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/tcr.201402100"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200001010-00004"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03473.x"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta4370"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-014-9969-y"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/009127002762491299"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(24)15022-2"}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09546634.2017.1363850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:24:48Z","timestamp":1770416688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09546634.2017.1363850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,17]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,2]]}},"alternative-id":["10.1080\/09546634.2017.1363850"],"URL":"https:\/\/doi.org\/10.1080\/09546634.2017.1363850","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijdt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}